Lv14
30 积分 2024-10-31 加入
Sibeprenlimab, which neutralizes A PRoliferation Inducing Ligand (APRIL), as a new approach to treating IgA nephropathy
3小时前
已完结
A reassessment of the MAdCAM-1 structure and its role in integrin recognition
2天前
求助中
An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis
2天前
已完结
P-148 Discovery of Novel Oral Peptide Antagonists of IL-23 Receptor that Are Efficacious in a Rat Model of IBD
2天前
已完结
MAdCAM-1: a newly identified microbial 'gut check' for T cells
13天前
已完结
A reassessment of the MAdCAM-1 structure and its role in integrin recognition
13天前
已关闭
EPHA5 mutation predicts the durable clinical benefit of immune checkpoint inhibitors in patients with lung adenocarcinoma
15天前
已完结
Regulation of topographic projection by the Eph family receptor Bsk (EphA5) and its ligands
16天前
已完结
Pharmacokinetics of Novel Oral Cyclic Peptide
20天前
已完结
Identification and Optimization of EphA2-Selective Bicycles for the Delivery of Cytotoxic Payloads
20天前
已完结
皖公网安备34019202002308
